Phenotypic characterization of pulmonary hypertension associated with left heart disease in contemporary practice: insights from the Re-PHIRE Trial
The Re-PHIRE trial provides one of the largest contemporary multi-country cohorts of patients with RHC-confirmed diagnosis of PH-LHD across the EF continuum and a wide PVR range, thereby capturing a spectrum of haemodynamic and clinical phenotypes.